• Users Online: 5772
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

Itraconazole: What clinicians should know?

De Doncker Piet, Pande Sushil, Richarz Ute, Garodia Nishant

Year : 2017| Volume: 3| Issue : 1 | Page no: 4-10

   This article has been cited by
 
1 Dissolution at acidic pH, not dermatoscopy, is the preferred method to test the quality of itraconazole pellets
Deepak Jakhar, Ishmeet Kaur, Raj Kumar Mehta
Journal of the American Academy of Dermatology. 2023; 88(5): e273
[Pubmed]  [Google Scholar] [DOI]
2 Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea
Bela Shah, Deval Mistry, Dharmender Jairam, Kajal Kansara, Rutvi Pandya, Presha Vasani, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan, Hanmant Barkate
Infection and Drug Resistance. 2023; Volume 16: 2409
[Pubmed]  [Google Scholar] [DOI]
3 A Randomized Control Study of Oral Itraconazole versus Itraconazole with Terbinafine in the Treatment of Dermatophytosis
Divya Sharma, Amandeep Saluja, Sanjay Meena, Kalpana Gupta
Clinical Dermatology Review. 2023; 7(3): 266
[Pubmed]  [Google Scholar] [DOI]
4 Efficacy of Terbinafine and Itraconazole Combination Therapy Versus Terbinafine or Itraconazole Monotherapy in the Management of Fungal Diseases: A Systematic Review and Meta-Analysis
Syed Hassan Tanvir Ramzi, Syed Abdullah Arif, Abdul Majid, Satesh Kumar, Hooria Shumail, Faiza Qudsia, Yumna Zainab, Giustino Varrassi, Mahima Khatri
Cureus. 2023;
[Pubmed]  [Google Scholar] [DOI]
5 Formulation and Characterization of Chitosan-Decorated Multiple Nanoemulsion for Topical Delivery In Vitro and Ex Vivo
Muhammad Rehan Malik, Fatemah Farraj Al-Harbi, Asif Nawaz, Adnan Amin, Arshad Farid, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Maitham A. Al Hawaj, Yousef N. Alhashem
Molecules. 2022; 27(10): 3183
[Pubmed]  [Google Scholar] [DOI]
6 Influence of Gender, Body Mass Index, and Age on the Pharmacokinetics of Itraconazole in Healthy Subjects: Non-Compartmental Versus Compartmental Analysis
Milijana N. Miljkovic, Nemanja Rancic, Aleksandra Kovacevic, Bojana Cikota-Aleksic, Ivan Skadric, Vesna Jacevic, Momir Mikov, Viktorija Dragojevic-Simic
Frontiers in Pharmacology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
7 Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis
Prashant Kesharwani, Mahak Fatima, Vanshikha Singh, Afsana Sheikh, Waleed H. Almalki, Virendra Gajbhiye, Amirhossein Sahebkar
Biomimetics. 2022; 7(4): 206
[Pubmed]  [Google Scholar] [DOI]
8 An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from Tinea cruris and Tinea corporis
Dattatray Gopal Saple, Sushrut Save, Devesh Kumar, Suneet Sood
F1000Research. 2022; 11: 1446
[Pubmed]  [Google Scholar] [DOI]
9 Itraconazole versus propranolol: therapeutic and pharmacologic effect on serum angiopoietin-2 in patients with infantile hemangioma
Hagar Bessar, Abdalla Hassan Kandil, Noha Mohammed Nasr, Fathia Khattab
Journal of Dermatological Treatment. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
10 Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions
Athanasios Tragiannidis,Anastasia Gkampeta,Maria Vousvouki,Eleni Vasileiou,Andreas H. Groll
Expert Opinion on Drug Safety. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
11 “Azole menace”-An underappreciated trigger perpetuating the epidemic of antifungal therapeutic failure in cutaneous mycoses
Sidharth Sonthalia,Amarendra Pandey,Ruchika Mehndiratta,Mahima Agrawal,Shukla Das,Shrishti Shreshtha
Dermatologic Therapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
12 In vitro activity of itraconazole against SARS-CoV-2
Ellen Van Damme,Sandra De Meyer,Denisa Bojkova,Sandra Ciesek,Jindrich Cinatl,Steven De Jonghe,Dirk Jochmans,Pieter Leyssen,Christophe Buyck,Johan Neyts,Marnix Van Loock
Journal of Medical Virology. 2021; 93(7): 4454
[Pubmed]  [Google Scholar] [DOI]
13 Preparation of Topical Itraconazole with Enhanced Skin/Nail Permeability and In Vivo Antifungal Efficacy against Superficial Mycosis
Laxman Subedi,Seung-Yub Song,Saurav Kumar Jha,Sung-Ho Lee,Rudra Pangeni,Kyo-Tan Koo,Beum Joon Kim,Seung-Sik Cho,Jin Woo Park
Pharmaceutics. 2021; 13(5): 622
[Pubmed]  [Google Scholar] [DOI]
14 Gender differences in concentration of itraconazole and hydroxyitraconazole
Tijana Stanojkovic,Milijana Miljkovic,Nemanja Rancic,Aleksandra Kovacevic,Viktorija Dragojevic-Simic
Halo 194. 2021; 27(1): 7
[Pubmed]  [Google Scholar] [DOI]
15 Drug interactions of azole antifungals
Navya Vanaja Sahadevan
Journal of Skin and Sexually Transmitted Diseases. 2021; 0: 1
[Pubmed]  [Google Scholar] [DOI]
16 The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options
Shyam B. Verma,Saumya Panda,Pietro Nenoff,Archana Singal,Shivprakash M. Rudramurthy,Silke Uhrlass,Anupam Das,Kavita Bisherwal,Dipika Shaw,Resham Vasani
Indian Journal of Dermatology, Venereology and Leprology. 2021; 0: 1
[Pubmed]  [Google Scholar] [DOI]
17 COMPARATIVE EFFICACY AND SAFETY OF SYSTEMIC TERBINAFINE AND ITRACONAZOLE IN RECALCITRANT TINEA CRURIS
Vasudha Sharma, Navyug Raj Singh, Tejinder Kaur, Inderpal Singh Grover
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. 2021; : 42
[Pubmed]  [Google Scholar] [DOI]
18 Comparative evaluation of efficacy and safety of terbinafine and itraconazole in the management of tinea corporis et cruris
Dhiraj Dhoot,Bela Shah,Shikha Shah,Neha Jangid,Gaurav Deshmukh
IP Indian Journal of Clinical and Experimental Dermatology. 2020; 6(3): 231
[Pubmed]  [Google Scholar] [DOI]
19 Intrinsic resistance to terbinafine among human and animal isolates of Trichophyton mentagrophytes related to amino acid substitution in the squalene epoxidase
Dominik Lagowski,Sebastian Gnat,Aneta Nowakiewicz,Marcelina Osinska,Mariusz Dylag
Infection. 2020;
[Pubmed]  [Google Scholar] [DOI]
20 Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis
Andi Dian Permana,Alejandro J. Paredes,Fabiana Volpe-Zanutto,Qonita Kurnia Anjani,Emilia Utomo,Ryan F. Donnelly
European Journal of Pharmaceutics and Biopharmaceutics. 2020; 154: 50
[Pubmed]  [Google Scholar] [DOI]
21 Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis
Priyanka Sharma,Mala Bhalla,Gurvinder P. Thami,Jagdish Chander
Journal of Dermatological Treatment. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
22 Antifungal combination therapy in dermatophytosis: a clinical insight
Priyanka Sharma,Mala Bhalla,Gurvinder P. Thami
Journal of Dermatological Treatment. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
23 Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation
Hyeongmin Kim,Sukkyun Jung,Sooho Yeo,Dohyun Kim,Young Chae Na,Gyiae Yun,Jaehwi Lee
Pharmaceutics. 2019; 11(4): 195
[Pubmed]  [Google Scholar] [DOI]
24 Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin – A prospective, randomized comparative study
Anuradha Bhatia,Bimal Kanish,DineshKumar Badyal,Prajakta Kate,Swati Choudhary
Indian Journal of Pharmacology. 2019; 51(2): 116
[Pubmed]  [Google Scholar] [DOI]

 

Read this article